Trevor Bedford Profile picture
18 Jan, 14 tweets, 8 min read
At this point, the countries with most genomic data to analyze spread of the variant virus belonging to cov-lineages.org B.1.1.7 lineage or @nextstrain clade 20I/501Y.V1 are the UK, Denmark and the USA. Here I compare growth rates of B.1.17 across these countries. 1/13
Working from @GISAID data, the UK has 18776 genomes, Denmark has 6089 genomes and the USA has 3093 genomes from specimens collected after Dec 15, 2020. Here, I'm looking at daily genomes with collection dates up to Jan 6 that were not pre-screened by "S dropout". 2/13
For the UK, we can see a steady increase in the frequency of sequenced variant viruses belonging to the B.1.1.7 lineage, reaching ~70% frequency at the end of December. Solid line is a 7 day sliding window average. 3/13
We can fit a logistic growth model to the frequency of B.1.1.7 in the UK data to estimate the rate of frequency increase through time. 4/13
And following @erikmvolz et al (medrxiv.org/content/10.110…) we can convert from a measured frequency growth rate to an estimate of increased transmissibility by assuming a particular generation time, which I take to be between 5 days and 6.5 days. 5/13
Doing so gives the following result where the observed saturation of variant frequency is well matched by the logistic growth model with an estimate of logistic growth rate of B.1.1.7 of 0.08 per day corresponding to an increase in transmission rate of 40-52%. 6/13
This result fits with more rigorous modeling studies by Vöhringer et al (virological.org/t/lineage-spec…) and @_nickdavies et al (cmmid.github.io/topics/covid19…), and the 30-50% increase in transmission is supported by secondary attack rate estimates from @PHE_uk (gov.uk/government/pub…). 7/13
We can do a similar analysis of genomic data from Denmark where we see an increase in B.1.1.7 frequency to ~3% over the course of December. Sparser bars are due to Denmark releasing specimen collection dates by week rather than by day. 8/13
Using the same logistic growth model, we get a logistic growth rate of B.1.1.7 of 0.07 per day in Denmark corresponding to an increase in transmission rate of 34-44%. 9/13
At the end of December the US frequency of B.1.1.7 was approximately ~1%. Recent samples used in this estimate are largely from New York, California, Wisconsin, Wyoming, Maryland and New Mexico. 10/13
The logistic growth model gives a logistic growth rate of B.1.1.7 of 0.08 per day in the US which corresponds to an increase in transmission rate of 42-55% although this estimate is noisy at this point. 11/13
Similar rates of frequency growth of lineage B.1.1.7 in different geographic contexts support biological increase in transmission rate of the 501Y.V1 variant. 12/13
Near real-time tracking of the spread of B.1.1.7 is possible due to efforts of @covidgenomicsuk in the UK, covid19genomics.dk in Denmark and @HealthNYGov, @CedarsSinai, @HealthNYGov, @CedarsSinai, @tcflab, @dho_lab, @health_wyoming, @NMDOH among others in the US. 13/13
Follow up #1: There was a typo in tweet 4/13. The correct logistic growth model is what's shown here (multiply by e^ rather than add by e^ in the denominator). Code is correct, typesetting was off.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Trevor Bedford

Trevor Bedford Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @trvrb

20 Jan
Important new study by Wibmer et al (biorxiv.org/content/10.110…) of neutralization by convalescent sera on wildtype vs 501Y.V2 variant viruses circulating in South Africa. It shows that mutations present in 501Y.V2 result in reduced neutralization capacity. 1/10
Here, I've replotted data from the preprint to make effect size a bit more clear. Each line is sera from one individual tested against wildtype virus on the left and 501Y.V2 variant virus on the right. Note the log y axis (as is common with this type of data). 2/10 Image
It's clear that 501Y.V2 often results in reductions of neutralization titer, quantified as "fold-reduction" where, for example, a 2-fold reduction in titer would mean that you need twice as much sera to neutralize the same amount of virus in the assay. 3/10
Read 10 tweets
14 Jan
After ~10 months of relative quiescence we've started to see some striking evolution of SARS-CoV-2 with a repeated evolutionary pattern in the SARS-CoV-2 variants of concern emerging from the UK, South Africa and Brazil. 1/19
In SARS-CoV-2, the viral spike protein and in particular the receptor binding domain (RBD) is a locus for important viral evolution and is the primary target for the human immune response (figure from science.sciencemag.org/content/367/64…). 2/19
There had been little evolution in the RBD until ~Oct 2020 when we saw RBD mutations start to spread. Perhaps chief among mutations of interest are E484K and N501Y which mutate nearby sites in the RBD. The evolution of these sites can be seen here: nextstrain.org/ncov/global?c=…. 3/19
Read 19 tweets
29 Dec 20
With data that has emerged in the last week, I'm now 80-90% convinced that infections by the UK variant virus (Pangolin lineage B.1.1.7, @nextstrain clade 20B/501Y.V1) result in, on average, more onward infections, ie are more transmissible. 1/10
My thinking primarily comes from three data points:
1. rapid increase in frequency of variant over wildtype
2. higher secondary attack rate of variant than wildtype
3. increased viral loads of variant over wildtype as measured by Ct
2/10
For point 1 (increase in frequency) we have pretty much the same data as of a week ago, where we see increasing frequency of variant over wildtype across the UK. This can be readily seen in this analysis by @TWenseleers. 3/10
Read 11 tweets
28 Dec 20
Given that the US has not detected SARS-CoV-2 variant viruses 501Y.V1 or 501Y.V2, what bounds can we place on their current frequency in the US based on sample counts? 1/12
So far, the US has not detected any cases that genetically match either the UK variant virus 501Y.V1 (nextstrain.org/ncov/europe?c=…) or the South African variant virus 501Y.V2 (nextstrain.org/ncov/africa?c=…). 2/12
However, because the US is generally slower at turnaround of specimens into SARS-CoV-2 sequences than the UK, we lack confidence that 501Y.V variants are absent from the US. 3/12
Read 13 tweets
23 Dec 20
Given the large discrepancy in specimens collected in Dec that were sequenced and shared between the US and the UK, I wanted to follow up on the relative quality of genomic surveillance in the US and the UK. 1/12
First thing to clarify, in the @nytopinion opinion piece yesterday (nytimes.com/2020/12/22/opi…), it's mentioned that "since Dec. 1, Britain has sequenced more than 3,700 coronavirus cases, compared with fewer than 40 cases in the United States, according to Trevor Bedford". 2/12
As of today, the UK has shared to @GISAID 23,377 genomes during Dec and the US has shared 8033 genomes. However, the UK turnaround time has been much faster with 5010 specimens that were collected in Dec shared vs 65 collected in Dec and shared by the US. 3/12
Read 12 tweets
22 Dec 20
Following up on general thoughts on antigenic drift of #COVID19 from this weekend, I wanted to discuss what we know about the new variant of SARS-CoV-2 thats emerged in the UK. 1/17
This variant is referred to as the B.1.1.7 lineage in cov-lineages.org nomenclature and clade 20B/501Y.V1 in @nextstrain nomenclature and can be seen here within circulating viral diversity, where the variant lineage is highlighted in orange (nextstrain.org/ncov/europe?c=…). 2/17
Broadly, I'd characterize the source of concern as arising from the combination of:
1. Multiple mutations that from sequence composition alone are suggestive of biological importance
2. Observed rapid epidemic spread
3/17
Read 17 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!